New horizons in tricuspid therapy – The tricvalve solution

Sponsored by OrbusNeich P&F

Session Coordinator: M. Haude

Speakers: K. Kiss, I. J. Amat-Santos, I. J. Amat-Santos, M. Haude, K. Kiss, R. Puri, O. Abdul-Jawad Altisent

Summary

In this session, you will get an overview of the TricValve system’s approach to tricuspid regurgitation and right heart disease, the TricValve’s preliminary data and the ongoing clinical trials, followed by a case demonstration.

This session was originally presented during AICT-AsiaPCR 2020.

Learning Objectives

To learn about the TricValve system’s approach to tricuspid regurgitation and right heart disease
To understand how this new generation of valve system may reduce the procedural time and operational errors
To obtain first insight on TricValve’s preliminary data and the ongoing clinical trials